Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Mayumi Nakagawa

Concepts (235)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Papillomavirus Infections
15
2024
170
4.360
Why?
Human papillomavirus 16
11
2021
44
3.430
Why?
Uterine Cervical Neoplasms
10
2024
299
3.180
Why?
Papillomavirus Vaccines
7
2021
69
3.120
Why?
Oncogene Proteins, Viral
11
2011
52
2.330
Why?
Papillomaviridae
7
2019
102
2.210
Why?
Repressor Proteins
9
2011
150
2.010
Why?
Epitopes, T-Lymphocyte
7
2018
25
1.810
Why?
Cancer Vaccines
3
2021
78
1.530
Why?
T-Lymphocytes
6
2021
318
1.370
Why?
Candida
4
2018
62
1.270
Why?
CD8-Positive T-Lymphocytes
6
2018
140
1.240
Why?
Cervix Uteri
3
2021
49
0.840
Why?
Uterine Cervical Dysplasia
2
2015
51
0.790
Why?
Immunity, Cellular
4
2013
64
0.700
Why?
Lymphocytes, Tumor-Infiltrating
1
2021
86
0.680
Why?
Epitopes
2
2015
62
0.670
Why?
Langerhans Cells
3
2018
11
0.660
Why?
Neoplasms
2
2021
1314
0.640
Why?
Viral Load
2
2019
81
0.620
Why?
Health Education
1
2021
157
0.620
Why?
Cell Cycle Checkpoints
1
2019
32
0.610
Why?
HLA Antigens
4
2006
55
0.580
Why?
Humans
43
2025
52441
0.560
Why?
Adult
21
2025
14205
0.550
Why?
Colorectal Neoplasms
1
2021
286
0.540
Why?
CD4-Positive T-Lymphocytes
3
2018
165
0.540
Why?
Female
29
2025
28277
0.530
Why?
Health Knowledge, Attitudes, Practice
1
2021
504
0.510
Why?
Plasma Exchange
2
2014
25
0.480
Why?
Cross Protection
1
2015
4
0.470
Why?
T-Lymphocytes, Regulatory
2
2016
81
0.470
Why?
Colposcopy
1
2015
17
0.450
Why?
Interleukin-12
2
2018
26
0.450
Why?
Adjuvants, Immunologic
2
2018
51
0.440
Why?
Immunity, Innate
1
2015
109
0.440
Why?
Interferon-gamma
2
2012
169
0.420
Why?
Health
1
2013
22
0.420
Why?
Lectins, C-Type
1
2013
31
0.420
Why?
Papillomavirus E7 Proteins
8
2018
30
0.410
Why?
Middle Aged
15
2025
13133
0.410
Why?
Young Adult
9
2021
4346
0.400
Why?
Patient Selection
1
2015
269
0.400
Why?
Afibrinogenemia
1
2012
5
0.380
Why?
Enzyme-Linked Immunospot Assay
1
2012
3
0.380
Why?
T-Lymphocytes, Cytotoxic
4
2009
64
0.370
Why?
Breast Neoplasms
1
2021
1203
0.370
Why?
Cell Proliferation
5
2021
1013
0.350
Why?
Vaginal Smears
3
2021
28
0.350
Why?
Warts
1
2010
14
0.340
Why?
Plateletpheresis
1
2010
7
0.340
Why?
Early Detection of Cancer
3
2021
185
0.340
Why?
Antigens, Fungal
1
2010
19
0.340
Why?
Blood Preservation
1
2010
27
0.340
Why?
Dermatitis
1
2010
36
0.330
Why?
Blood Proteins
1
2010
84
0.330
Why?
Anaphylaxis
1
2010
69
0.320
Why?
Cells, Cultured
5
2021
1583
0.310
Why?
Antigens, Viral
2
2009
44
0.290
Why?
Immunotherapy
1
2010
251
0.290
Why?
Telemedicine
1
2015
490
0.290
Why?
Blood Platelets
1
2010
239
0.290
Why?
Human papillomavirus 18
1
2008
9
0.290
Why?
Host-Pathogen Interactions
2
2021
130
0.270
Why?
Dendritic Cells
1
2008
132
0.270
Why?
Hematopoietic Stem Cell Transplantation
2
2025
600
0.270
Why?
Vaccinia virus
1
2007
6
0.260
Why?
Immunoenzyme Techniques
1
2007
134
0.260
Why?
Immunophenotyping
1
2007
115
0.260
Why?
Neoplasm Staging
2
2025
768
0.250
Why?
Aged
10
2025
10242
0.240
Why?
Blood Component Removal
1
2025
17
0.230
Why?
Cell Line, Tumor
5
2021
1429
0.230
Why?
Isoantibodies
1
2004
28
0.220
Why?
Neoplasm Grading
2
2021
127
0.220
Why?
Lead
1
2004
32
0.220
Why?
Infant, Very Low Birth Weight
1
2004
53
0.220
Why?
Neutropenia
1
2004
113
0.210
Why?
Endometrial Neoplasms
1
2025
144
0.210
Why?
DNA, Viral
3
2011
134
0.210
Why?
Oropharyngeal Neoplasms
1
2024
19
0.210
Why?
Anus Neoplasms
1
2024
26
0.210
Why?
Hematopoietic Stem Cells
1
2025
180
0.210
Why?
Blood Transfusion
1
2004
126
0.200
Why?
Coinfection
1
2024
41
0.200
Why?
Penile Neoplasms
1
2024
45
0.200
Why?
Adolescent
5
2021
6713
0.200
Why?
High-Throughput Nucleotide Sequencing
2
2021
178
0.200
Why?
Capsid Proteins
1
2002
24
0.190
Why?
Antibody Formation
1
2002
51
0.190
Why?
Practice Guidelines as Topic
1
2025
498
0.190
Why?
Genes, T-Cell Receptor
1
2021
5
0.180
Why?
Clone Cells
3
2007
76
0.180
Why?
Cytokines
2
2016
622
0.180
Why?
Treatment Outcome
3
2021
5508
0.180
Why?
Clinical Trials, Phase I as Topic
1
2021
24
0.180
Why?
Pilot Projects
2
2021
725
0.180
Why?
Mass Screening
2
2021
354
0.170
Why?
Remission Induction
1
2021
218
0.170
Why?
Lymphocyte Activation
1
2021
161
0.170
Why?
Cystadenocarcinoma, Serous
1
2021
73
0.170
Why?
Videotape Recording
1
2021
26
0.170
Why?
Left-Right Determination Factors
1
2020
1
0.170
Why?
Nodal Protein
1
2020
3
0.170
Why?
Amino Acid Sequence
3
2008
576
0.170
Why?
Mammography
1
2021
97
0.170
Why?
Focus Groups
1
2021
201
0.160
Why?
Multiple Myeloma
2
2025
3013
0.160
Why?
Enzyme-Linked Immunosorbent Assay
3
2010
234
0.160
Why?
Metagenome
1
2019
40
0.160
Why?
Male
10
2024
26874
0.150
Why?
Glioblastoma
1
2020
89
0.150
Why?
Dose-Response Relationship, Drug
2
2016
1365
0.150
Why?
Feasibility Studies
1
2021
404
0.150
Why?
Parenteral Nutrition
1
2019
28
0.150
Why?
Up-Regulation
1
2020
462
0.150
Why?
Health Behavior
1
2021
256
0.150
Why?
Transplantation Conditioning
1
2019
93
0.140
Why?
DNA
1
2021
544
0.140
Why?
Time Factors
2
2021
2987
0.140
Why?
Bacteria
1
2019
223
0.140
Why?
Leukocytes, Mononuclear
2
2016
122
0.140
Why?
HLA-B Antigens
2
2008
8
0.130
Why?
Age Factors
1
2021
1120
0.130
Why?
Cell Line
2
2012
1020
0.130
Why?
Ovarian Neoplasms
1
2021
455
0.130
Why?
Brain Neoplasms
1
2020
302
0.130
Why?
Histocompatibility Antigens Class II
2
2008
35
0.130
Why?
Retrospective Studies
5
2025
6694
0.130
Why?
Vaccines, Subunit
1
2016
15
0.120
Why?
Head and Neck Neoplasms
1
2019
289
0.120
Why?
Body Mass Index
1
2019
701
0.120
Why?
Molecular Sequence Data
2
2008
778
0.120
Why?
Adaptive Immunity
1
2015
34
0.120
Why?
Chromatography, Liquid
1
2016
245
0.110
Why?
Leukocyte Count
2
2004
71
0.110
Why?
Peptides
2
2006
239
0.110
Why?
Factor VIII
1
2014
22
0.110
Why?
Tandem Mass Spectrometry
1
2016
255
0.110
Why?
ADAM Proteins
1
2014
21
0.110
Why?
Purpura, Thrombotic Thrombocytopenic
1
2014
15
0.110
Why?
Proteome
1
2016
175
0.110
Why?
Antigens, CD1
1
2013
9
0.110
Why?
Mannose-Binding Lectins
1
2013
8
0.110
Why?
Receptors, Pattern Recognition
1
2013
4
0.110
Why?
Indicators and Reagents
1
2013
36
0.110
Why?
Intracellular Space
1
2013
23
0.100
Why?
Skin Tests
1
2013
59
0.100
Why?
Vaccination
1
2016
294
0.100
Why?
Cadherins
1
2013
61
0.100
Why?
Proteomics
1
2016
332
0.100
Why?
Communication
1
2015
255
0.100
Why?
Antigens, CD
1
2013
213
0.100
Why?
Research Design
1
2015
368
0.100
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
580
0.090
Why?
Rural Health Services
1
2015
177
0.090
Why?
Socioeconomic Factors
1
2015
609
0.090
Why?
Longitudinal Studies
2
2005
756
0.090
Why?
Injections, Intralesional
1
2010
32
0.090
Why?
Isotonic Solutions
1
2010
21
0.080
Why?
Platelet Transfusion
1
2010
33
0.080
Why?
P-Selectin
1
2010
27
0.080
Why?
Sodium Chloride
1
2010
55
0.080
Why?
Platelet Aggregation
1
2010
76
0.080
Why?
Platelet Activation
1
2010
46
0.080
Why?
Hypersensitivity
1
2010
80
0.080
Why?
Japan
2
2025
40
0.080
Why?
Complement Factor I
1
2008
2
0.070
Why?
Polymerase Chain Reaction
1
2010
458
0.070
Why?
HLA-A Antigens
1
2008
11
0.070
Why?
Haplotypes
1
2008
95
0.070
Why?
Antigen Presentation
1
2008
25
0.070
Why?
Immunologic Memory
1
2008
31
0.070
Why?
Histocompatibility Antigens Class I
1
2008
47
0.070
Why?
Prognosis
2
2025
2100
0.070
Why?
Signal Transduction
2
2020
1724
0.070
Why?
DNA, Recombinant
1
2007
15
0.070
Why?
Animals
2
2019
13485
0.070
Why?
Genes, MHC Class I
1
2006
11
0.060
Why?
Arkansas
1
2013
2013
0.060
Why?
Binding, Competitive
1
2006
92
0.060
Why?
Polymorphism, Single Nucleotide
1
2008
506
0.060
Why?
Leukapheresis
1
2025
18
0.060
Why?
Antigens, CD34
1
2025
73
0.060
Why?
Calgranulin B
1
2005
4
0.060
Why?
Calgranulin A
1
2005
5
0.060
Why?
Cryopreservation
1
2025
41
0.060
Why?
Epitope Mapping
1
2004
6
0.060
Why?
Immunomagnetic Separation
1
2004
8
0.060
Why?
Societies, Medical
1
2025
200
0.050
Why?
Risk Factors
1
2013
3971
0.050
Why?
Transplantation, Autologous
1
2025
479
0.050
Why?
Phosphorylation
2
2020
536
0.050
Why?
Sensitivity and Specificity
1
2005
871
0.050
Why?
Mutation
1
2008
1331
0.050
Why?
Tumor Virus Infections
1
2002
47
0.050
Why?
Antibodies, Viral
1
2002
113
0.050
Why?
Lactobacillus
1
2021
4
0.050
Why?
Immunoglobulin G
1
2002
193
0.040
Why?
SOX Transcription Factors
1
2021
4
0.040
Why?
Cytodiagnosis
1
2021
42
0.040
Why?
Neuroendocrine Cells
1
2021
9
0.040
Why?
Biological Specimen Banks
1
2021
21
0.040
Why?
Neoplasm Recurrence, Local
1
2025
639
0.040
Why?
Cytoplasm
1
2021
93
0.040
Why?
Cobalt
1
2020
16
0.040
Why?
Neoplastic Stem Cells
1
2021
88
0.040
Why?
Recurrence
1
2002
680
0.040
Why?
Cell Hypoxia
1
2020
82
0.040
Why?
Vulnerable Populations
1
2020
51
0.040
Why?
Cohort Studies
1
2004
1576
0.040
Why?
Epithelial-Mesenchymal Transition
1
2020
56
0.040
Why?
Cell Movement
1
2021
271
0.040
Why?
Community Health Workers
1
2020
58
0.040
Why?
Multivariate Analysis
1
2021
601
0.040
Why?
Parenteral Nutrition, Total
1
2019
28
0.040
Why?
Cell Survival
1
2020
598
0.040
Why?
Sequence Analysis, DNA
1
2019
220
0.040
Why?
Cell Differentiation
1
2021
667
0.040
Why?
Phenotype
1
2021
792
0.040
Why?
Models, Biological
1
2021
735
0.040
Why?
Linear Models
1
2019
288
0.040
Why?
Immunity, Humoral
1
2018
23
0.030
Why?
Aged, 80 and over
1
2025
3449
0.030
Why?
Infant, Newborn
1
2004
2871
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2020
853
0.030
Why?
Autoantibodies
1
2014
118
0.030
Why?
Mice, Inbred C57BL
1
2018
1888
0.020
Why?
Immunosuppressive Agents
1
2014
248
0.020
Why?
Combined Modality Therapy
1
2014
641
0.020
Why?
Genetics, Population
1
2008
13
0.020
Why?
Alleles
1
2008
279
0.020
Why?
Mice
1
2018
5899
0.020
Why?
Casein Kinase II
1
2005
9
0.010
Why?
Cell Division
1
2005
288
0.010
Why?
Nakagawa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description